Rekombinanter VCP Antikörper
Kurzübersicht für Rekombinanter VCP Antikörper (ABIN7938537)
Target
Alle VCP Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- VCP antibody (rAb), 100 μg (Clone 3G23)
-
Aufreinigung
- Protein A Chromatography
-
Immunogen
- This antibody was raised against the VCP fusion protein.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:5000-1:50000 dilution IHC: 1:50-1:500 dilution
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- Purified IgG in PBS, pH 7.3, with 50 % glycerol and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze/thaw cycles by aliquoting items into single-use fractions,Keep all reagents on ice when not in storage
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Some products may be shipped at room temperature. This will not affect their stability or performance. Avoid repeated freeze/thaw cycles by aliquoting items into single-use fractions for storage at -20°C for up to 2 years. Keep all reagents on ice when not in storage.
-
Haltbarkeit
- 24 months
-
-
- VCP (Valosin Containing Protein (VCP))
-
Andere Bezeichnung
- VCP
-
Hintergrund
-
Background_Plain: VCP (Valosin-containing protein), also known as TER ATPase and 15S Mg2+-ATPase p97 subunit, belongs to the AAA ATPase family. VCP was first identified as a result of attempts to clone a putative peptide hormone called valosin. It was found that the cloned cDNA encoded a ubiquitously expressed 90 kDa cytosolic protein, termed VCP, which showed none of the characteristics of a peptide hormone precursor. Defects in VCP are the cause of inclusion body myopathy with early-onset Paget disease and frontotemporal dementia (IBMPFD) and amyotrophic lateral sclerosis type 14 with or without frontotemporal dementia (ALS14).
Aliases: Valosin-containing protein
-
Molekulargewicht
- 89 kDa
-
Pathways
- ER-Nucleus Signaling, Positive Regulation of Endopeptidase Activity, Ubiquitin Proteasome Pathway
Target
-